KD-370 Phase II study.
Phase 2
- Conditions
- The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.
- Registration Number
- JPRN-jRCT2080222866
- Lead Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
More than 2 months old, less than 60 months old
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method